As a rule: no. In hepatitis C, liver disease can progress rapidly or slowly, no matter how high or low viral load (HCV RNA) is. This is where hepatitis C differs from other viruses such as hepatitis B or HIV.

Presumably, hepatitis C does not damage the liver cells directly, but they are destroyed in the fight between the immune system and the virus. Even in people with concomitant HIV infection («co-infection»), the level of hepatitis C virus is not meaningful, although it has been suspected for several years. However, there is one exception with hepatitis C as well: in liver transplants, hepatitis C can actually be worse if the viral load is higher. During this disease, many drugs are taken, including Buy Harvoni Online.

Hepatitis C is almost always curable today. Meanwhile, several new drugs have been approved. These have significantly improved both the efficacy and the tolerability of the therapy.

Most therapies are performed today for 8 to 12 weeks. Patients are considered cured if no HCV RNA is detectable in the blood at three and six months after the end of treatment.

Prior to 2014, Peg-interferon and ribavirin were still needed as part of any hepatitis C treatment. From 2011 to 2014 these z.T. still combined with a protease inhibitor (Boceprevir and Telaprevir). Due to strong side effects and interactions interferon-containing therapies are no longer used today. Ribavirin is still used in certain cases for the new therapies.